Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages 3277-3284

  Lehto, Hanna Riikka ^a   Pärkkä, Jussi ^a   Borra, Ronald ^a   Tuunanen, Helena ^a   Lepomaki, Virva ^a   Parkkola, Riitta ^a   Knuuti, Juhani ^a   Nuutila, Pirjo ^a   Iozzo, Patricia ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ADIPONECTIN; CHEMOATTRACTANT; FATTY ACID; GLUCOSE; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MACROPHAGE CHEMOATTRACTANT PROTEIN 1; MACROPHAGE CHEMOTACTIC FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INSULIN SENSITIVITY; LIPID STORAGE; MALE; METABOLIC REGULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN SECRETION; SKELETAL MUSCLE; SPECTROSCOPY;

ADIPOKINES; ADIPONECTIN; ADULT; AGED; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOCARDIUM; PYRAZINES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84866170649     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1219     Document Type: Article

References (33)

1. Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, De-Fronzo RA 2004 Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab 89:4649-4655 (Pubitemid 39244483)
2. Nisoli E, Vettor R, Tonello C, Macor C, Federspil G, Carruba MO 1999 Nutrient channelling-regulated peroxisome proliferator-activated receptor-γ-2 (PPARγ-2) and leptin gene expression in human subcutaneous fat. Diabetologia 42:495-497 (Pubitemid 29148411)
3. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L 1998 A nutrientsensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688 (Pubitemid 28289657)
4. Garcia-Lorda P, Nash W, Roche A, Pi-Sunyer FX, Laferrere B 2003 Intralipid/heparin infusion suppresses serum leptin in humans. Eur J Endocrinol 148:669-676 (Pubitemid 36758298)
5. Iozzo P, Lautamaki R, Borra R, Lehto HR, Bucci M, Viljanen A, Parkka J, Lepomaki V, Maggio R, Parkkola R, Knuuti J, Nuutila P 2009 Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 94:4472-4482
6. Goodpaster BH, He J, Watkins S, Kelley DE 2001 Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86:5755-5761 (Pubitemid 33152620)
7. Kankaanpää M, Lehto HR, Pärkkä JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P 2006 Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91:4689-4695 (Pubitemid 44833458)
8. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ 2008 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52:1793-1799
9. Hammer S, van der Meer RW, Lamb HJ, de Boer HH, Bax JJ, de Roos A, Romijn JA, Smit JW 2008 Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 295:E714-E718
10. Stirling C, McAleer M, Reckless JP, Campbell RR, Mundy D, Betteridge DJ, Foster K 1985 Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin Sci (Lond) 68:83-88 (Pubitemid 15177954)
11. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA 2005 Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54:3148-3153 (Pubitemid 43334368)
12. Rigazio S, Lehto HR, Tuunanen H, Någren K, Kankaanpaa M, Simi C, Borra R, Naum AG, Parkkola R, Knuuti J, Nuutila P, Iozzo P 2008 The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans. Am J Physiol Endocrinol Metab 295:E413-E419
13. Tuunanen H, Engblom E, Naum A, Någren K, Hesse B, Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J 2006 Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114:2130-2137 (Pubitemid 44747893)
14. Mohrman DE, Heller LJ 2006 Cardiovascular physiology. 6th ed. Stamford, CT: Appleton, Lange
15. Bucci M, Borra R, Någren K, Pärkkä JP, Del Ry S, Maggio R, Tuunanen H, Viljanen T, Cabiati M, Rigazio S, Taittonen M, Pagotto U, Parkkola R, Opie LH, Nuutila P, Knuuti J, Iozzo P 31 July 2011 Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans. Cardiovasc Ther 10.1111/j.1755-5922.2011.00275.x
16. Bucci M, Borra R, Någren K, Maggio R, Tuunanen H, Oikonen V, DelRy S, Viljanen T, Taittonen M, Rigazio S, Giannessi D, Parkkola R, Knuuti J, Nuutila P, Iozzo P 2011 Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities. Am J Physiol Endocrinol Metab 301:E105-E112
17. Provencher SW 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679 (Pubitemid 23360802)
18. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT 1999 Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276(5 Pt 1):E977-E989 (Pubitemid 29249618)
19. Nikolaidis MG, Petridou A, Mougios V 2006 Comparison of the phospholipid and triacylglycerol fatty acid profile of rat serum, skeletal muscle and heart. Physiol Res 55:259-265
20. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O 1994 Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495 (Pubitemid 24113193)
21. Clarke NE, Mosher RE 1952 The water and electrolyte content of the human heart in congestive heart failure with and without digitalization. Circulation 5:907-914
22. van der Meer RW, Hammer S, Smit JW, Frölich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ 2007 Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 56:2849-2853 (Pubitemid 350223617)
23. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
24. de Jongh RT, Serné EH, Ijzerman RG, de Vries G, Stehouwer CD 2004 Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 53:2873-2882 (Pubitemid 39425913)
25. Bülow J, Madsen J, Hojgaard L 1990 Reversibility of the effects on local circulation of high lipid concentrations in blood. Scand J Clin Lab Invest 50:291-296 (Pubitemid 20163690)
26. Fagot-Campagna A, Balkau B, Simon D, Warnet JM, Claude JR, Ducimetière P, Eschwège E 1998 High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 27:808-813 (Pubitemid 28504968)
27. Florian JP, Pawelczyk JA 2010 Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci (Lond) 118:61-69
28. Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teräs M, Voipio-Pulkki LM, Haaparanta M, Solin O, Wegelius U, Yki-Järvinen H 1994 Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans.AmJ Physiol 267(6 Pt 1):E941-E946
29. van Loon LJ, Manders RJ,KoopmanR, Kaastra B, Stegen JH, Gijsen AP, Saris WH, Keizer HA 2005 Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients. Diabetologia 48:2097-2107 (Pubitemid 41416922)
30. Dubé JJ, Amati F, Stefanovic-RacicM,Toledo FG, Sauers SE, Goodpaster BH 2008 Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am J Physiol Endocrinol Metab 294:E882-E888
31. Dullaart RP, Riemens SC, Meinardi JR, Wolffenbuttel BH, Sluiter WJ 2005 Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox. Scand J Clin Lab Invest 65:523-531 (Pubitemid 41499254)
32. Bernstein EL, Koutkia P, Ljungquist K, Breu J, Canavan B, Grinspoon S 2004 Acute regulation of adiponectin by free fatty acids. Metabolism 53:790-793 (Pubitemid 38880913)
33. WormD, Vinten J, Vaag A, Henriksen JE, Beck-NielsenH2000 The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients. Eur J Endocrinol 143:389-395